Hypnosis eases cancer procedure anxiety, small trial suggests

NCT ID NCT03755895

Completed Symptom relief Sponsor: Institut de Cancérologie de Lorraine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 2 trial tested whether formal hypnosis, alongside standard care, could reduce anxiety and pain in 68 cancer patients undergoing brachytherapy. Patients received either standard care with Kalinox or standard care plus formal hypnosis. The study measured anxiety using a standard questionnaire and pain with a numeric scale. The goal was to see if adding hypnosis improves patient comfort during the procedure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: formal hypnosis
What this could lead to: If it works, this could offer a drug-free way to ease anxiety and pain during brachytherapy, improving patient comfort.
What could go wrong: This is a small, Phase 2 trial with only 68 participants, so results may not apply to everyone. Hypnosis may not work for all patients, and the study is already completed, so no further development is planned.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRACHYTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRACHYTHERAPY CANCER

Contacts and locations

Locations

Institut de Cancérologie de Lorraine

Vandœuvre-lès-Nancy, 54519, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.